Fan M, Huang Y, Chen Z, Xia Y, Chen A, Lu D, Wu Y, Zhang N, Qian J. Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis. Stem Cell Res Ther. 2019;10(1):150
Bareeqa SB, Bibi F, Ahmed SI, Samar SS. Advancement in Stem Cell Therapy for Ischemic Myocardial Cell: A Systematic Review. Int J Hematol Oncol Stem Cell Res. 2018, 12(4):282-290
Rahim F, Arjmand B, Shirbandi K, Payab M, Larijani B. Stem cell therapy for patients with diabetes: a systematic review and metaanalysis of metabolomics-based risks and benefits. Stem Cell Investig. 2018, 4;5:40.
Borakati A, Mafi R, Mafi P, Khan WS. A Systematic Review And Meta-Analysis of Clinical Trials of Mesenchymal Stem Cell Therapy for Cartilage Repair. Curr Stem Cell Res Ther. 2018;13(3):215-225.
Elbuluk A, Einhorn TA, Iorio R. A Comprehensive Review of Stem-Cell Therapy. JBJS Rev. 2017; 5(8):e15.
Oh SK, Jeon SR. Current Concept of Stem Cell Therapy for Spinal Cord Injury: A Review. Korean J Neurotrauma. 2016; 12(2):40- 46.
Sharp TE 3rd, George JC. Stem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment. Front Oncol. 2014, 3;4:299
Behfar, A.; Yamada, S.; Crespo-Diaz, R.; Nesbitt, J.J.; Rowe, L.A.; Perez-Terzic, C.; Gaussin, V.; Homsy, C.; Bartunek, J. & Terzic A. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J. Am. Coll. Cardiol. 2010, 56:721-34.
Aasen, T.; Raya, A.; Barrero, M. J.; Garreta, E.; Consiglio, A.; Gonzalez, F.; Vassena, R.; Bilic, J.; Pekarik, V. & Tiscornia, G. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 2008, 26, 1276-1284.
Dimos, J.T.; Rodolfa, K.T.; Niakan, K.K.; Weisenthal, L.M.; Mitsumoto, H.; Chung, W.; Croft, G.F.; Saphier, G.; Leibel, R.; Goland, R.; Wichterle, H.; Henderson, C.E. & Eggan, K.(2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321:1218–1221.
Erba P, Terenghi G, Kingham PJ. Neural differentiation and therapeutic potential of adipose tissue-derived stem cells. Curr Stem Cell Res Ther 2010; 5: 153-60.
Gonzales, C. & Pedrazzini, T. (2009). Progenitor cell therapy for heart disease. Experimental Cell Research, 315: 3077–3085.
Hao J., et al. Human parthenogenetic embryonic stem cells: one potential resource for cell therapy. Sci China C Life Sci. 52(7):599-602, 2009.
Hida, N., et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells 26(7):1695-704, 2008.
Hipp, J., Atala, A. Sources of Stem Cells for Regenerative Medicine. Stem Cell Reviews 4: 3-11, 2008.
Kuçi S, Kuçi Z, Latifi-Pupovci H, Niethammer D, Handgretinger R, Schumm M, et al. Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine. Curr Stem Cell Res Ther 2009; 4: 107-17.
Mathiasen, A.B.; Haack-Sørensen, M. & Kastrup, J. (2009). Mesenchymal stromal cells for cardiovascular repair: current status and future challenges. Future Cardiol. 5:605–17
Moretti, A.; Bellin, M.; Welling, A.; Jung, C. B.; Lam, J. T;, Bott-Flugel, L.; Dorn, T.; Goedel, A.; Hohnke, C.; Hofmann, F; Seyfarth, M.; Daniel Sinnecker, D.; Schömig, A. & Laugwitz, K.L. (2010). Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397–1409.
Sadan O, Melamed E, Offen D. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases. Expert Opin Biol Ther 2009; 9: 1487-97.
Sudkamp NP. Autologous chondrocyte implantation for treatment of focal cartilage defects in patients age 40 years and older: A matched-pair analysis with 2-year follow-up. Am J Sports Med 2010; 38: 2410-6
Takahashi, K. et al. Induction of pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell, 131:1-12, 2007.
Undale AH, Westendorf JJ, Yaszemski MJ, Khosla S. Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc 2009; 84: 893-902.
Ye, Z.; Zhan, H.; Mali, P.; Dowey, S.; Williams, D. M.; Jang, Y. Y.; Dang, C. V.; Spivak, J. L.; Moliterno, A. R. & Cheng, L. (2009). Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114, 5473-5480.
Abdel-Latif, A.; Bolli, R.; Tleyjeh, I.M.; Montori, V.M.; Perin, E.C.; Hornung, C.A.; Zuba-Surma, E.K.; Al-Mallah, M. & Dawn, B. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007, 167:989-97
Concise review: scientific and ethical roadblocks to human embryonic stem cell therapy. Gruen L, Grabel L. Stem Cells. 2006,24(10):2162-9
Aggarwal, S. & Pittenger, MF. . Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815–1822
